Home > Insider Trading > Filing (0001104659-21-116446)

Filing Details

Accession Number:: 0001104659-21-116446
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-09-16 17:15:39
Reporting Period:: 2021-09-14

Accepted Time:: 2021-09-16 17:15:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1851182	Future Health Esg Corp.	FHLT	Blank Checks (6770)	862305680

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1880403	A Travis Morgan	C/O Future Health Esg Corp. 8 The Green, Suite #12081 Dover DE 19901	Chief Financial Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	Disposition	2021-09-14	614,900	$0.01	103,850	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
See Footnote	Warrant	Acquisiton	2021-09-14	273,507	$1.00	0	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
273,507			No	4	P	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	562,781	Indirect	See Footnote
Common Stock, Par Value $0.0001 Per Share	2,587	Indirect	See Footnote
Common Stock, Par Value $0.0001 Per Share	129,514	Indirect	See Footnote

Footnotes

Represents shares transferred by MB Equity, LLC to anchor investors in connection with the Issuer's initial public offering at the same price per share as MB Equity, LLC initially paid for such shares.
Includes up to 13,546 shares subject to forfeiture by MB Equity, LLC if the underwriters in the Issuer's initial public offering do not exercise the over-allotment option in full.
The shares are held directly by MB Equity, LLC. The Reporting Person disclaims beneficial ownership of the securities held by MB Equity, LLC other than the reported securities except to the extent of his pecuniary interest therein.
Includes up to 73,406 shares subject to forfeiture by m2 Enterprises Holdings, LLC if the underwriters in the Issuer's initial public offering do not exercise the over-allotment option in full.
The shares are held directly by m2 Enterprises Holdings, LLC, of which the Reporting Person is the sole manager.
Includes up to 337 shares subject to forfeiture by hc1.com, Inc. if the underwriters in the Issuer's initial public offering do not exercise the over-allotment option in full.
The shares are held directly by hc1.com, Inc. The Reporting Person disclaims beneficial ownership of the securities held by hc1.com, Inc. other than the reported securities except to the extent of his pecuniary interest therein.
Includes up to 16,893 shares subject to forfeiture by Future Health ESG Associates 1, LLC if the underwriters in the Issuer's initial public offering do not exercise the over-allotment option in full.
The securities are held directly by Future Health ESG Associates 1, LLC, of which the Reporting Person is a manager, and indirectly by m2 Enterprises Holdings, LLC, an individual retirement account (IRA) in the name of the Reporting Person, and an IRA in the name of the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. The Reporting Person disclaims beneficial ownership of the securities held by Future Health ESG Associates 1, LLC other than the reported securities except to the extent of his pecuniary interest therein.
Each warrant will become exercisable 30 days after the completion of the Issuer's initial business combination. Each warrant will expire five years after the completion of the Issuer's initial business combination. Each warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment in the event of certain capital-raising or reorganization transactions.